Refine
Document Type
- Article (3)
- Conference Proceeding (1)
- Working Paper (1)
Has Fulltext
- yes (5)
Is part of the Bibliography
- no (5)
Keywords
- Cirrhosis (1)
- Genetics (1)
- Genome-wide association studies (1)
- Liver diseases (1)
- Platelets (1)
- Portal veins (1)
- Prostaglandin (1)
- SARS-CoV-2 (1)
- Thrombosis (1)
- Thromboxane (1)
Institute
The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3,4,5,6,7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease.
"Wir sehen uns vor Gericht!" – Oft eskalieren Konflikte zu einem Rechtsstreit, ohne dass die Beteiligten nachgedacht haben, ob dies der beste Weg ist. Im Verhältnis zwischen Bürger und Staat gibt es wenig zu überlegen: Binnen Monatsfrist muss klagen, wer eine Entscheidung der Verwaltung nicht bestandskräftig werden lassen will. Dabei ist ein Rechtsstreit manchmal langwierig und oft teuer. Das Urteil am Ende des Instanzenzuges kann schließlich "Steine statt Brot" bedeuten, selbst wenn der Rechtsstreit gewonnen ist. Seit Langem etablieren sich daher "alternative" Konfliktlösungsverfahren, allen voran die Mediation: Die Konfliktparteien erarbeiten freiwillig und selbstbestimmt eine von ihnen akzeptierte, interessenorientierte Lösung, indem sie kooperativ verhandeln mit einem Mediator an ihrer Seite, einem neutralen und allparteilichen Dritten.
Im Jahr 2014 beschäftigten sich sowohl der Deutsche Juristentag als auch die Vereinigung der Deutschen Staatsrechtslehrer mit dem Reformbedarf im Gerichtsverfassungs- bzw. (Zivil-)Prozessrecht sowie mit dem Wandel der Justiz. Das Arbeitspapier ist der methodischen Frage gewidmet, welcher Innovationen die Prozessrechtswissenschaft bedarf, um sowohl Vollzugsdefizite als auch Reformentwicklungen im Recht der Dritten Gewalt sachgerecht untersuchen zu können. Im Mittelpunkt steht die Übertragung der im Verwaltungsrecht inzwischen etablierten Perspektive der Rechtswissenschaft als Steuerungswissenschaft auf das Prozessrecht. Es wird u.a. gezeigt, dass dieser Ansatz wissenschaftsgeschichtlich anschlussfähig ist und – als Referenzbeispiel – für das Verständnis des richterlichen Verfahrensermessens ertragreich sein kann.
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
(2019)
Background: Prostanoids are important regulators of platelet aggregation and thrombotic arterial diseases. Their involvement in the development of portal vein thrombosis, frequent in decompensated liver cirrhosis, is still not investigated.
Methods: Therefore, we used pro-thrombotic venous milieu generation by bare metal stent transjugular intrahepatic portosystemic shunt insertion, to study the role of prostanoids in decompensated liver cirrhosis. Here, 89 patients receiving transjugular intrahepatic portosystemic shunt insertion were included in the study, and baseline levels of thromboxane B2, prostaglandin D2 and prostaglandin E2 were measured in the portal and the hepatic vein.
Results: While the hepatic vein contained higher levels of thromboxane B2 than the portal vein, levels of prostaglandin E2 and D2 were higher in the portal vein (all P<0.0001). Baseline concentrations of thromboxane B2 in the portal vein were independently associated with an increase of portal hepatic venous pressure gradient during short term follow-up, as an indirect sign of thrombogenic potential (multivariable P = 0.004). Moreover, severity of liver disease was inversely correlated with portal as well as hepatic vein levels of prostaglandin D2 and E2 (all P<0.0001).
Conclusions: Elevated portal venous thromboxane B2 concentrations are possibly associated with the extent of thrombogenic potential in patients with decompensated liver cirrhosis.
Trial registration: ClinicalTrials.gov identifier: NCT03584204.
Challenges of FAIR phase 0
(2018)
After two-year's shutdown, the GSI accelerators plus the latest addition of storage ring CRYRING, will be back into operation in 2018 as the FAIR phase 0 with the goal to fulfill the needs of scientific community and the FAIR accelerators and detector development. Even though GSI has been well known for its operation of a variety of ion beams ranging from proton up to uranium for multi research areas such as nuclear physics, astrophysics, biophysics, material science, the upcoming beam time faces a number of challenges in re-commissioning its existing circular accelerators with brand new control system and upgrade of beam instrumentations, as well as in rising failures of dated components and systems. The cycling synchrotron SIS18 has been undergoing a set of upgrade measures for fulfilling future FAIR operation, among which many measures will also be commissioned during the upcoming beam time. This paper presents the highlights of the challenges such as re-establishing the high intensity heavy ion operation as well as parallel operation mode for serving multi users. The status of preparation including commissioning results will also be reported.